Citius Board News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Citius board. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Citius Board Today - Breaking & Trending Today

Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2024 Financial Results and Provides Business Update

Resubmitted LYMPHIR™ Biologics License Application; awaiting PDUFA date
Completed enrollment in the Mino-Lok® Pivotal Phase 3 trial
CRANFORD, N.J., Feb. 14, 2024 /PRNewswire/ Citius. ....

New Jersey , United States , Greg Salsburg , Ilanit Allen , Robert Smith , Citius Pharma , Leonard Mazur , Drug Administration , Citius Pharmaceuticals Inc , Securities Exchange , Citius Oncology Inc , Company Nasdaq , Prnewswire Citius Pharmaceuticals Inc , Investor Relations For Citius Pharmaceuticals , Development Rd Expenses , Exchange Commission , Biologics License Application , Pivotal Phase , Prescription Drug User Fee Act , Tenx Keane Acquisition , Citius Oncology , Citius Board , Annual Meeting , Mino Lok Phase , Halo Lido Phase , Citius Pharmaceuticals ,

Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2024 Financial Results and Provides Business Update

/PRNewswire/ Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development. ....

New Jersey , United States , Leonard Mazur , Greg Salsburg , Ilanit Allen , Robert Smith , Citius Pharma , Citius Pharmaceuticals Inc , Development Rd Expenses , Securities Exchange , Prnewswire Citius Pharmaceuticals Inc , Drug Administration , Citius Oncology Inc , Company Nasdaq , Investor Relations For Citius Pharmaceuticals , Exchange Commission , Biologics License Application , Pivotal Phase , Prescription Drug User Fee Act , Tenx Keane Acquisition , Citius Oncology , Citius Board , Annual Meeting , Mino Lok Phase , Halo Lido Phase , Citius Pharmaceuticals ,

Citius Pharmaceuticals Announces Nomination of Pharmaceutical Executive Robert J. Smith to its Board of Directors

Independent Director nominee expected to be elected at Annual Shareholders Meeting in March 2024
CRANFORD, N.J., Jan. 23, 2024 /PRNewswire/ Citius Pharmaceuticals, Inc. , a late-stage. ....

United States , New York , University Of Rochester , Ilanit Allen , Leonard Mazur , Robertj Smith , Greg Salsburg , Citius Pharma , Investment Advisory Committee For Venture Investors , Company Nasdaq , Exchange Commission , Operations Committee , Citius Pharmaceuticals Inc , Bamboo Therapeutics Inc , Securities Exchange , Iterum Therapeutics , Alliance For Regenerative Medicine , Investor Relations For Citius Pharmaceuticals , Wyeth Pharmaceuticals , Jersey State Biotechnology Association , Business Advisory Board Of Ocugen Inc , Prnewswire Citius Pharmaceuticals Inc , Pennsylvania Biotechnology Association , Foundation For Cell , Business Administration , Life Sciences ,

Citius Pharmaceuticals (CTXR) Appoints Robert J. Smith to its Board

Citius Pharmaceuticals (CTXR) Appoints Robert J. Smith to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New York , United States , University Of Rochester , Robertj Smith , Leonard Mazur , Immunotherapeutics Inc , Jersey State Biotechnology Association , Business Advisory Board Of Ocugen Inc , Foundation For Cell , Pennsylvania Biotechnology Association , Life Sciences , Investment Advisory Committee For Venture Investors , Operations Committee , Citius Pharmaceuticals Inc , Alliance For Regenerative Medicine , Wyeth Pharmaceuticals , Bamboo Therapeutics Inc , Iterum Therapeutics , Citius Pharmaceuticals , Citius Annual Shareholder Meeting , Citius Board , Senior Vice President , Global Gene Therapy Business , Global Licensing , Iterum Therapeutics Limited , New Jersey State Biotechnology Association ,

Citius Pharmaceuticals Announces Nomination of Pharmaceutical Executive Robert J. Smith to its Board of Directors

Citius Pharmaceuticals, Inc. ("Citius" or the "Company") , a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products today announced the nomination of seasoned pharmaceutical. ....

United States , University Of Rochester , New York , Ilanit Allen , Citius Pharma , Greg Salsburg , Robertj Smith , Leonard Mazur , Business Advisory Board Of Ocugen Inc , Foundation For Cell , Operations Committee , Securities Exchange , Wyeth Pharmaceuticals , Company Nasdaq , Jersey State Biotechnology Association , Business Administration , Alliance For Regenerative Medicine , Pennsylvania Biotechnology Association , Exchange Commission , Bamboo Therapeutics Inc , Prnewswire Citius Pharmaceuticals Inc , Investment Advisory Committee For Venture Investors , Citius Pharmaceuticals Inc , Iterum Therapeutics , Investor Relations For Citius Pharmaceuticals , Life Sciences ,